Masimo Corporation (MASI): Price and Financial Metrics

Masimo Corporation (MASI): $143.50

4.16 (+2.99%)

POWR Rating

Component Grades














  • Quality is the dimension where MASI ranks best; there it ranks ahead of 92.83% of US stocks.
  • The strongest trend for MASI is in Growth, which has been heading up over the past 179 days.
  • MASI's current lowest rank is in the Momentum metric (where it is better than 16.1% of US stocks).

MASI Stock Summary

  • MASI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 953.4 -- higher than 96.65% of US-listed equities with positive expected earnings growth.
  • For MASI, its debt to operating expenses ratio is greater than that reported by merely 0.5% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.21 for Masimo Corp; that's greater than it is for only 13.3% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Masimo Corp are APPS, CPRX, BCOV, ICAD, and TTWO.
  • Visit MASI's SEC page to see the company's official filings. To visit the company's web site, go to

MASI Valuation Summary

  • In comparison to the median Healthcare stock, MASI's price/sales ratio is 234.21% higher, now standing at 12.7.
  • MASI's price/sales ratio has moved up 8.1 over the prior 171 months.
  • MASI's price/sales ratio has moved up 8.1 over the prior 171 months.

Below are key valuation metrics over time for MASI.

Stock Date P/S P/B P/E EV/EBIT
MASI 2021-08-31 12.7 10.7 66.8 55.7
MASI 2021-08-30 12.9 10.9 68.0 56.8
MASI 2021-08-27 13.0 11.0 68.2 57.0
MASI 2021-08-26 12.9 10.9 68.0 56.8
MASI 2021-08-25 13.1 11.1 69.1 57.7
MASI 2021-08-24 13.3 11.3 70.2 58.7

MASI Growth Metrics

    The 3 year net income to common stockholders growth rate now stands at 118.29%.
  • Its 4 year cash and equivalents growth rate is now at 333.1%.
  • Its 5 year cash and equivalents growth rate is now at 333.1%.
MASI's revenue has moved up $592,412,000 over the prior 70 months.

The table below shows MASI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,239.153 264.754 229.647
2021-09-30 1,206.629 231.569 232.058
2021-06-30 1,177.327 190.161 223.692
2021-03-31 1,173.162 227.868 229.229
2020-12-31 1,143.744 210.963 240.302
2020-09-30 1,096.2 216.769 222.554

MASI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MASI has a Quality Grade of B, ranking ahead of 88.45% of graded US stocks.
  • MASI's asset turnover comes in at 0.714 -- ranking 51st of 186 Medical Equipment stocks.
  • BLFS, NVNO, and ZYXI are the stocks whose asset turnover ratios are most correlated with MASI.

The table below shows MASI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-02 0.714 0.647 0.384
2021-07-03 0.702 0.642 0.380
2021-04-03 0.705 0.643 0.387
2021-01-02 0.700 0.650 0.408
2020-09-26 0.705 0.660 0.413
2020-06-27 0.720 0.669 0.414

MASI Price Target

For more insight on analysts targets of MASI, see our MASI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $298.80 Average Broker Recommendation 1.56 (Moderate Buy)

MASI Stock Price Chart Interactive Chart >

Price chart for MASI

MASI Price/Volume Stats

Current price $143.50 52-week high $305.21
Prev. close $139.34 52-week low $112.07
Day low $140.15 Volume 950,700
Day high $144.64 Avg. volume 972,023
50-day MA $137.84 Dividend yield N/A
200-day MA $224.14 Market Cap 7.96B

Masimo Corporation (MASI) Company Bio

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies worldwide. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company was founded in 1989 and is based in Irvine, California.

MASI Latest News Stream

Event/Time News Detail
Loading, please wait...

MASI Latest Social Stream

Loading social stream, please wait...

View Full MASI Social Stream

Latest MASI News From Around the Web

Below are the latest news stories about Masimo Corp that investors may wish to consider to help them evaluate MASI as an investment opportunity.

Needham Upgrades Masimo To Buy, With Price Target Of $205

Needham has upgraded Masimo Corp (NASDAQ: MASI ) to Buy from Hold with a $205 price target . According to analyst Mike Matson, the selloff in the stock following the company''s Sound United acquisition was "overdone" as the deal should prove to be highly accretive to earnings. On 16 February, Masimo shares closed 37% lower at $144.62. Related: Masimo Stock … Full story available on

Benzinga | February 18, 2022

Masimo upgraded at Needham after concerns over acquisition triggered selloff

After a loss of more than a third on Wednesday, Masimo <> shares continue to trade higher for the second straight session buoyed by an upgrade at Needham, which calls the selloff…

Seeking Alpha | February 18, 2022

Masimo Corporation 2021 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 17, 2022

DEI Sales, Inc. -- Moody's says Sound United's B2 CFR and stable outlook unaffected by agreement to be acquired by Masimo

Announcement: Moody's says Sound United's B2 CFR and stable outlook unaffected by agreement to be acquired by MasimoGlobal Credit Research - 17 Feb 2022New York, February 17, 2022 -- Moody's Investors Service ("Moody's") said that DEI Sales, Inc.'s (dba Sound United, B2, stable) announcement that it had entered into a definitive agreement to be acquired by Masimo Corporation ("Masimo", not rated), for a purchase price of approximately $1.025 billion.

Yahoo | February 17, 2022

Masimo's (MASI) CEO Joe Kiani on Q4 2021 Results - Earnings Call Transcript

Masimo Corporation (MASI) Q4 2021 Earnings Conference Call February 15, 2022 4:30 PM ET Company Participants Eli Kammerman – Vice President-Business Development and Investor Relations Joe Kiani – Chairman and Chief Executive Officer Micah Young – Executive Vice President and Chief Financial Officer Conference Call Participants Matt Taylor – UBS...

SA Transcripts on Seeking Alpha | February 16, 2022

Read More 'MASI' Stories Here

MASI Price Returns

1-mo 27.02%
3-mo -8.86%
6-mo -48.40%
1-year -33.44%
3-year 4.02%
5-year 64.92%
YTD -50.99%
2021 9.09%
2020 69.80%
2019 47.21%
2018 26.62%
2017 25.82%

Continue Researching MASI

Want to see what other sources are saying about Masimo Corp's financials and stock price? Try the links below:

Masimo Corp (MASI) Stock Price | Nasdaq
Masimo Corp (MASI) Stock Quote, History and News - Yahoo Finance
Masimo Corp (MASI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7729 seconds.